146 related articles for article (PubMed ID: 12694496)
1. Post-transplantation chronic graft-versus-host disease with overlapping features similar to those of various collagen diseases.
Tsunemi Y; Ihn H; Nakamura K; Tamaki K
Int J Dermatol; 2003 Apr; 42(4):292-4. PubMed ID: 12694496
[No Abstract] [Full Text] [Related]
2. A clinical review: cutaneous manifestations of acute and chronic graft-versus-host disease following bone marrow transplantation.
Tanaka K; Sullivan KM; Shulman HM; Sale GE; Tanaka A
J Dermatol; 1991 Jan; 18(1):11-7. PubMed ID: 2050901
[No Abstract] [Full Text] [Related]
3. [The skin manifestations of the graft vs. host reaction].
Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
[TBL] [Abstract][Full Text] [Related]
4. Blaschkoid Acute Graft-vs-Host Disease.
Gupta V; Arava S; Ramam M
JAMA Dermatol; 2018 Apr; 154(4):494-495. PubMed ID: 29387872
[No Abstract] [Full Text] [Related]
5. Linear and dermatomal cutaneous graft-versus-host disease.
Cohen PR; Hymes SR
South Med J; 1994 Jul; 87(7):758-61. PubMed ID: 8023213
[TBL] [Abstract][Full Text] [Related]
6. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
Ziemer M; Thiele JJ; Gruhn B; Elsner P
J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
[No Abstract] [Full Text] [Related]
7. Skin biopsies in bone marrow transplantation.
Vermeer BJ; van der Spek-Keijser LM; Fibbe WE
Lancet; 1994 Jul; 344(8915):75-6. PubMed ID: 7912389
[No Abstract] [Full Text] [Related]
8. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F
Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949
[No Abstract] [Full Text] [Related]
9. Cutaneous manifestations of chronic graft-versus-host disease.
Andrews ML; Robertson I; Weedon D
Australas J Dermatol; 1997 May; 38(2):53-62; quiz 63-4. PubMed ID: 9159958
[TBL] [Abstract][Full Text] [Related]
10. [Graft vs host disease of the skin].
MartÃn Ortega E
Med Clin (Barc); 1990 Feb; 94(5):180-3. PubMed ID: 2325478
[No Abstract] [Full Text] [Related]
11. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
12. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
13. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous chronic graft-versus-host disease localized to the field of total lymphoid irradiation.
Okamoto S; Takahashi S; Inoue T; Tojo A; Tani K; Kikuchi A; Shimizu H; Nishikawa T; Ikeda Y; Asano S
Bone Marrow Transplant; 1996 Jan; 17(1):111-3. PubMed ID: 8673042
[TBL] [Abstract][Full Text] [Related]
15. Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation.
Wagner JL; Flowers ME; Longton G; Storb R; Martin P
Biol Blood Marrow Transplant; 2001; 7(4):239-40. PubMed ID: 11349811
[No Abstract] [Full Text] [Related]
16. Epithelioid granulomas in post-transplantation chronic graft-vs.-host disease.
Tsunemi Y; Ihn H; Saeki H; Tamaki K
Br J Dermatol; 2003 Oct; 149(4):898-9. PubMed ID: 14616396
[No Abstract] [Full Text] [Related]
17. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation.
Hood AF; Vogelsang GB; Black LP; Farmer ER; Santos GW
Arch Dermatol; 1987 Jun; 123(6):745-50. PubMed ID: 3555353
[TBL] [Abstract][Full Text] [Related]
18. Pathology of bone marrow transplantation.
Bombi JA; Palou J; Bruguera M; Feliu E; Martin-Ortega E; Rozman C; Cardesa A
Semin Diagn Pathol; 1992 Aug; 9(3):220-31. PubMed ID: 1523360
[TBL] [Abstract][Full Text] [Related]
19. Epidermal damage in skin of allogeneic marrow recipients: relative importance of chemotherapy, conditioning and graft v. host disease.
Norton J; Sloane JP
Histopathology; 1992 Dec; 21(6):529-34. PubMed ID: 1468751
[TBL] [Abstract][Full Text] [Related]
20. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
